| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPRENAL.00252.2009 |
| P698 | PubMed publication ID | 19656914 |
| P50 | author | Gerardo Gamba | Q42324007 |
| P2093 | author name string | Norma A Bobadilla | |
| Cristino Cruz | |||
| Joyce Trujillo | |||
| Norma Uribe | |||
| Rafael Valdes | |||
| Victoria Ramírez | |||
| P2860 | cites work | Ischemic injury to kidney induces glomerular podocyte effacement and dissociation of slit diaphragm proteins Neph1 and ZO-1 | Q24645152 |
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
| Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity | Q28564455 | ||
| Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats | Q28565932 | ||
| Magnesium supplementation prevents chronic cyclosporine nephrotoxicity via adjusting nitric oxide synthase activity | Q28574063 | ||
| Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors | Q28581291 | ||
| Arginine feeding modifies cyclosporine nephrotoxicity in rats | Q33905120 | ||
| Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 | ||
| Aldosterone in chronic kidney and cardiac disease | Q35205745 | ||
| eNOS at a glance | Q35782010 | ||
| Aldosterone in the development and progression of renal injury | Q35807297 | ||
| NO bioavailability, endothelial dysfunction, and acute renal failure: new insights into pathophysiology. | Q35836003 | ||
| Endothelial injury and dysfunction: role in the extension phase of acute renal failure. | Q35836394 | ||
| The role of mitochondria in ischemia/reperfusion injury in organ transplantation | Q35836412 | ||
| Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation | Q36158031 | ||
| The mineralocorticoid receptor and oxidative stress | Q36158043 | ||
| Rho-kinase is an important therapeutic target in cardiovascular medicine | Q36186014 | ||
| Acute renal failure: much more than a kidney disease | Q36418682 | ||
| Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade | Q36689814 | ||
| Protecting the kidney during critical illness | Q36782825 | ||
| A rapid urine test for early detection of kidney injury. | Q37331901 | ||
| Role of aldosterone in the remnant kidney model in the rat. | Q37358980 | ||
| A direct effect of aldosterone on endothelin-1 gene expression in vivo. | Q40184067 | ||
| Rapid effects of aldosterone on clonal human vascular smooth muscle cells. | Q40232321 | ||
| Effects of adrenalectomy and chronic adrenal corticosteroid replacement on potassium transport in rat kidney | Q40927262 | ||
| Inhibition of renal rho kinase attenuates ischemia/reperfusion-induced injury | Q41886605 | ||
| The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo | Q42697165 | ||
| Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease | Q43743641 | ||
| Glutathione peroxidase activity in selenium-deficient rat liver | Q43897516 | ||
| Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity. | Q44242743 | ||
| Endothelial nitric oxide synthase expression in ischemia-reperfusion injury after living related-donor renal transplantation | Q44246375 | ||
| Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats | Q44390510 | ||
| Nongenomic vascular action of aldosterone in the glomerular microcirculation | Q44560788 | ||
| Effect of aldosterone on renal transforming growth factor-beta | Q44886467 | ||
| Endothelial nitric oxide contributes to the renal protective effects of ischemic preconditioning | Q45016676 | ||
| Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction | Q45062038 | ||
| Kidney ischemia-reperfusion regulates expression and distribution of tubulin subunits, beta-actin and rho GTPases in proximal tubules | Q45089834 | ||
| Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease | Q45251122 | ||
| Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway | Q45264980 | ||
| Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study. | Q46571307 | ||
| Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells | Q46681426 | ||
| Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. | Q46713499 | ||
| Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats | Q48546780 | ||
| Role of endothelin in cyclosporine-induced glomerular dysfunction. | Q54322975 | ||
| Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. | Q54592700 | ||
| Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone | Q57275237 | ||
| P433 | issue | 4 | |
| P921 | main subject | reperfusion injury | Q1413991 |
| P304 | page(s) | F932-42 | |
| P577 | publication date | 2009-08-05 | |
| P1433 | published in | American Journal of Physiology - Renal Physiology | Q2610177 |
| P1476 | title | Adrenalectomy prevents renal ischemia-reperfusion injury | |
| P478 | volume | 297 |
| Q57275226 | AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease |
| Q34069043 | Attenuation of renal ischemia and reperfusion injury by human adrenomedullin and its binding protein |
| Q38503836 | Epigenetic regulation in the acute kidney injury (AKI) to chronic kidney disease transition (CKD). |
| Q39400991 | Gastroprotective effects of montelukast and Nigella sativa oil against corticosteroid-induced gastric damage: they are much more than antiasthmatic drugs |
| Q36108356 | Hsp72 is an early and sensitive biomarker to detect acute kidney injury. |
| Q35613312 | Human ghrelin protects animals from renal ischemia-reperfusion injury through the vagus nerve. |
| Q42566448 | Increased endothelin-1 vasoconstriction in mesenteric resistance arteries after superior mesenteric ischaemia-reperfusion |
| Q35830032 | Mild ischemic injury leads to long-term alterations in the kidney: amelioration by spironolactone administration |
| Q43063544 | Mineralocorticoid Receptor Antagonism in AKI: A New Hope? |
| Q38120300 | Neurohormonal interactions on the renal oxygen delivery and consumption in haemorrhagic shock-induced acute kidney injury. |
| Q64061901 | Pirfenidone prevents acute kidney injury in the rat |
| Q44202978 | Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury |
| Q46394125 | Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury |
| Q95395038 | The authors reply |
| Q90576341 | Vitamin D Ameliorates Kidney Ischemia Reperfusion Injury via Reduction of Inflammation and Myofibroblast Expansion |
Search more.